Dimethyl fumarate Neuraxpharm Umoja wa Ulaya - Kilithuania - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Umoja wa Ulaya - Kilithuania - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Umoja wa Ulaya - Kilithuania - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetilfumaratas - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresantai - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Umoja wa Ulaya - Kilithuania - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetilfumaratas - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresantai - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Mylan Umoja wa Ulaya - Kilithuania - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Tecfidera Umoja wa Ulaya - Kilithuania - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimetilfumaratas - išsėtinė sklerozė - imunosupresantai - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Vumerity Umoja wa Ulaya - Kilithuania - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Dimethyl fumarate STADA Litwania - Kilithuania - SMCA (Valstybinė vaistų kontrolės tarnyba)

dimethyl fumarate stada

stada arzneimittel ag - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 120 mg - dimethyl fumarate

Dimethyl fumarate STADA Litwania - Kilithuania - SMCA (Valstybinė vaistų kontrolės tarnyba)

dimethyl fumarate stada

stada arzneimittel ag - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 240 mg - dimethyl fumarate

Dimtruzic Litwania - Kilithuania - SMCA (Valstybinė vaistų kontrolės tarnyba)

dimtruzic

sandoz d.d. - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 120 mg - dimethyl fumarate